NASDAQ : PHAR
-$0.2 (-1.49%)
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 1 | 13.33M | 14.4M | 13.9M | 6.36M | 6.87M | 6.63M |
| 2027-09-30 | 1 | 12.92M | 13.96M | 13.47M | 6.17M | 6.66M | 6.43M |
| 2027-06-30 | 1 | 11.55M | 12.48M | 12.04M | 5.51M | 5.95M | 5.75M |
| 2027-03-31 | 1 | 9.72M | 10.5M | 10.13M | 4.64M | 5.01M | 4.84M |
| 2026-12-31 | 1 | 13.89M | 15.01M | 14.49M | 6.63M | 7.16M | 6.91M |
| 2026-09-30 | 2 | 12.57M | 13.58M | 13.08M | 6M | 6.48M | 6.24M |
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 1 | 1.33M | 1.47M | 1.4M | 35.33M | 38.17M | 36.84M |
| 2027-09-30 | 1 | 1.33M | 1.47M | 1.4M | 34.24M | 37M | 35.7M |
| 2027-06-30 | 1 | 664.14K | 734.53K | 701.4K | 30.6M | 33.07M | 31.91M |
| 2027-03-31 | 1 | - | - | - | 25.76M | 27.83M | 26.85M |
| 2026-12-31 | 1 | 7.13M | 7.88M | 7.53M | 36.82M | 39.79M | 38.39M |
| 2026-09-30 | 2 | 4.6M | 6.9M | 5.75M | 33.32M | 36M | 34.66M |
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 1 | 111.84M | 120.84M | 116.6M | 1 | 0.01893758 | 0.02094446 | 0.02 |
| 2027-09-30 | 1 | 108.38M | 117.1M | 113M | 1 | 0.01893758 | 0.02094446 | 0.02 |
| 2027-06-30 | 1 | 96.87M | 104.67M | 101M | 1 | 0.00946879 | 0.01047223 | 0.01 |
| 2027-03-31 | 1 | 81.53M | 88.09M | 85M | 0 | 0 | 0 | 0 |
| 2026-12-31 | 1 | 116.56M | 125.94M | 121.52M | 1 | 0.10163 | 0.1124 | 0.10733 |
| 2026-09-30 | 2 | 105.47M | 113.96M | 109.72M | 2 | 0.0656 | 0.0984 | 0.082 |